Besides, research has shown the automated ELISA can detect clinically relevant proteins [e.g., prostate-specific antigen (PSA)] in serum from patients (Rissin et al., 2010) with prostate cancer. This evidence concerns the gene KLK3 and Familial prostate cancer.